Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Correction to: Estimated prevalence of ulcerative colitis and Crohn's disease in Japan in 2015: an analysis of a nationwide survey.

Murakami Y, Nishiwaki Y, Oba MS, Asakura K, Ohfuji S, Fukushima W, Suzuki Y, Nakamura Y.

J Gastroenterol. 2019 Oct 23. doi: 10.1007/s00535-019-01637-y. [Epub ahead of print]

PMID:
31642989
2.

Lower dietary variety is a relevant factor for malnutrition in older Japanese home-care recipients: a cross-sectional study.

Tsuji T, Yamamoto K, Yamasaki K, Hayashi F, Momoki C, Yasui Y, Ohfuji S, Fukushima W, Habu D.

BMC Geriatr. 2019 Jul 26;19(1):197. doi: 10.1186/s12877-019-1206-z.

3.

Estimated prevalence of ulcerative colitis and Crohn's disease in Japan in 2014: an analysis of a nationwide survey.

Murakami Y, Nishiwaki Y, Oba MS, Asakura K, Ohfuji S, Fukushima W, Suzuki Y, Nakamura Y.

J Gastroenterol. 2019 Dec;54(12):1070-1077. doi: 10.1007/s00535-019-01603-8. Epub 2019 Jul 15. Erratum in: J Gastroenterol. 2019 Oct 23;:.

PMID:
31309327
4.

The association between environmental factors and the development of Crohn's disease with focusing on passive smoking: A multicenter case-control study in Japan.

Kondo K, Ohfuji S, Watanabe K, Yamagami H, Fukushima W, Ito K, Suzuki Y, Hirota Y; Japanese Case-Control Study Group for Crohn's disease.

PLoS One. 2019 Jun 7;14(6):e0216429. doi: 10.1371/journal.pone.0216429. eCollection 2019.

5.

Nationwide epidemiologic study of norovirus-related hospitalization among Japanese older adults.

Ohfuji S, Kondo K, Ito K, Kase T, Maeda A, Fukushima W, Masuda T, Kano M.

BMC Infect Dis. 2019 May 9;19(1):400. doi: 10.1186/s12879-019-4007-2.

6.

Japanese periodical nationwide epidemiologic survey of aberrant portal hemodynamics.

Ohfuji S, Furuichi Y, Akahoshi T, Kage M, Obara K, Hashizume M, Matsuura T, Fukushima W, Nakamura Y.

Hepatol Res. 2019 Aug;49(8):890-901. doi: 10.1111/hepr.13343. Epub 2019 Apr 25.

7.

Association between dietary iron and zinc intake and development of ulcerative colitis: A case-control study in Japan.

Kobayashi Y, Ohfuji S, Kondo K, Fukushima W, Sasaki S, Kamata N, Yamagami H, Fujiwara Y, Suzuki Y, Hirota Y; Japanese Case-Control Study Group for Ulcerative Colitis.

J Gastroenterol Hepatol. 2019 Oct;34(10):1703-1710. doi: 10.1111/jgh.14642. Epub 2019 Mar 21.

PMID:
30821862
8.

Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study.

Suzuki K, Kondo K, Washio M, Nakashima K, Kan S, Imai S, Yoshimura K, Ota C, Ohfuji S, Fukushima W, Hirota Y.

Hum Vaccin Immunother. 2019;15(9):2171-2177. doi: 10.1080/21645515.2019.1584023. Epub 2019 Apr 15.

9.

Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study.

Ohfuji S, Ito K, Inoue M, Ishibashi M, Kumashiro H, Hirota Y, Kayano E, Ota N.

BMC Infect Dis. 2019 Jan 28;19(1):95. doi: 10.1186/s12879-019-3719-7.

10.

A new approach to risk stratification using fetal MRI to predict outcomes in congenital diaphragmatic hernia: the preliminary retrospective single institutional study.

Yokoi A, Ohfuji S, Yoshimoto S, Sugioka Y, Akasaka Y, Funakoshi T.

Transl Pediatr. 2018 Oct;7(4):356-361. doi: 10.21037/tp.2018.09.01.

11.

Nationwide Survey of Pediatric Inpatients With Hand, Foot, and Mouth Disease, Herpangina, and Associated Complications During an Epidemic Period in Japan: Estimated Number of Hospitalized Patients and Factors Associated With Severe Cases.

Takechi M, Fukushima W, Nakano T, Inui M, Ohfuji S, Kase T, Ito K, Kondo K, Maeda A, Shimizu H, Hirota Y.

J Epidemiol. 2019 Sep 5;29(9):354-362. doi: 10.2188/jea.JE20180060. Epub 2018 Nov 10.

12.

Effects of a Public Subsidy Program for Mumps Vaccine on Reducing the Disease Burden in Nagoya City, Japan.

Ozaki T, Goto Y, Nishimura N, Nakano T, Kumihashi H, Kano M, Ohfuji S.

Jpn J Infect Dis. 2019 Mar 25;72(2):106-111. doi: 10.7883/yoken.JJID.2018.276. Epub 2018 Oct 31.

13.

Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.

Motoyama H, Tamori A, Kubo S, Uchida-Kobayashi S, Takemura S, Tanaka S, Ohfuji S, Teranishi Y, Kozuka R, Kawamura E, Hagihara A, Morikawa H, Enomoto M, Murakami Y, Kawada N.

PLoS One. 2018 Jul 24;13(7):e0201423. doi: 10.1371/journal.pone.0201423. eCollection 2018.

14.

Prior vaccinations improve immunogenicity of inactivated influenza vaccine in young children aged 6 months to 3 years: A cohort study.

Ito K, Mugitani A, Irie S, Ishibashi M, Takasaki Y, Shindo S, Yokoyama T, Yamashita Y, Shibao K, Koyanagi H, Fukushima W, Ohfuji S, Maeda A, Kase T, Hirota Y.

Medicine (Baltimore). 2018 Jul;97(29):e11551. doi: 10.1097/MD.0000000000011551.

15.

Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial.

Nakashima K, Aoshima M, Ohfuji S, Yamawaki S, Nemoto M, Hasegawa S, Noma S, Misawa M, Hosokawa N, Yaegashi M, Otsuka Y.

Hum Vaccin Immunother. 2018;14(8):1923-1930. doi: 10.1080/21645515.2018.1455476. Epub 2018 May 14.

16.

Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.

Motoyama H, Tamori A, Kubo S, Uchida-Kobayashi S, Takemura S, Tanaka S, Ohfuji S, Teranishi Y, Kozuka R, Kawamura E, Hagihara A, Morikawa H, Enomoto M, Murakami Y, Kawada N.

PLoS One. 2018 Mar 13;13(3):e0194163. doi: 10.1371/journal.pone.0194163. eCollection 2018. Erratum in: PLoS One. 2018 Jul 24;13(7):e0201423.

17.

Protective Effect of Maternal Influenza Vaccination on Influenza in Their Infants: A Prospective Cohort Study.

Ohfuji S, Deguchi M, Tachibana D, Koyama M, Takagi T, Yoshioka T, Urae A, Ito K, Kase T, Maeda A, Kondo K, Fukushima W, Hirota Y; Osaka Pregnant Women Influenza Study Group.

J Infect Dis. 2018 Mar 5;217(6):878-886. doi: 10.1093/infdis/jix629.

18.

Hepatic Mastocytosis in Japanese Black Cattle.

Ohfuji S.

Vet Pathol. 2018 Jan;55(1):182-186. doi: 10.1177/0300985817736115. Epub 2017 Oct 19.

PMID:
29050542
19.

Oseltamivir use and severe abnormal behavior in Japanese children and adolescents with influenza: Is a self-controlled case series study applicable?

Fukushima W, Ozasa K, Okumura A, Mori M, Hosoya M, Nakano T, Tanabe T, Yamaguchi N, Suzuki H, Mori M, Hatayama H, Ochiai H, Kondo K, Ito K, Ohfuji S, Nakamura Y, Hirota Y.

Vaccine. 2017 Aug 24;35(36):4817-4824. doi: 10.1016/j.vaccine.2017.07.007.

PMID:
28818475
20.

Estimating influenza disease burden among pregnant women: Application of self-control method.

Ohfuji S, Deguchi M, Tachibana D, Koyama M, Takagi T, Yoshioka T, Urae A, Fukushima W, Hirota Y; Osaka Pregnant Women Influenza Study Group.

Vaccine. 2017 Aug 24;35(36):4811-4816. doi: 10.1016/j.vaccine.2017.07.006.

21.

Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.

Kondo K, Suzuki K, Washio M, Ohfuji S, Fukushima W, Maeda A, Hirota Y; Study Group for Pneumonia in the Elderly Individuals.

Vaccine. 2017 Aug 24;35(36):4806-4810. doi: 10.1016/j.vaccine.2017.07.005.

22.

Control selection and confounding factors: A lesson from a Japanese case-control study to examine acellular pertussis vaccine effectiveness.

Ohfuji S, Okada K, Nakano T, Ito H, Hara M, Kuroki H, Hirota Y.

Vaccine. 2017 Aug 24;35(36):4801-4805. doi: 10.1016/j.vaccine.2017.07.004.

23.

Key points in evaluating immunogenicity of pandemic influenza vaccines: A lesson from immunogenicity studies of influenza A(H1N1)pdm09 vaccine.

Ohfuji S, Kobayashi M, Ide Y, Egawa Y, Saito T, Kondo K, Ito K, Kase T, Maeda A, Fukushima W, Hirota Y.

Vaccine. 2017 Sep 18;35(39):5303-5308. doi: 10.1016/j.vaccine.2017.07.092. Epub 2017 Aug 4. Review.

24.

Immunogenicity study to investigate the interchangeability among three different types of polio vaccine: A cohort study in Japan.

Ohfuji S, Ito K, Ishibashi M, Shindo S, Takasaki Y, Yokoyama T, Yokoyama T, Yamashita Y, Shibao K, Nakano T, Tsuru T, Irie S, Hirota Y.

Medicine (Baltimore). 2017 Jun;96(23):e7073. doi: 10.1097/MD.0000000000007073.

25.

Timing and outcome of stoma closure in very low birth weight infants with surgical intestinal disorders.

Mochizuki K, Hayakawa M, Urushihara N, Miyake H, Yokoi A, Shiraishi J, Fujinaga H, Ohashi K, Esumi G, Ohfuji S, Amae S, Yanai T, Furukawa T, Tazuke Y, Minagawa K, Okuyama H.

Surg Today. 2017 Aug;47(8):1001-1006. doi: 10.1007/s00595-017-1498-6. Epub 2017 Feb 28.

PMID:
28247106
26.

Factors associated with functional limitations in the daily living activities of Japanese hip osteoarthritis patients.

Kondo K, Jingushi S, Ohfuji S, Sofue M, Itoman M, Matsumoto T, Hamada Y, Shindo H, Takatori Y, Yamada H, Yasunaga Y, Ito H, Mori S, Owan I, Fujii G, Ohashi H, Fukushima W, Maeda A, Inui M, Takahashi S, Hirota Y.

Int J Rheum Dis. 2017 Oct;20(10):1372-1382. doi: 10.1111/1756-185X.12955. Epub 2016 Dec 10.

27.

Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy.

Nakashima K, Aoshima M, Ohfuji S, Suzuki K, Katsurada M, Katsurada N, Misawa M, Otsuka Y, Kondo K, Hirota Y.

Hum Vaccin Immunother. 2017 Mar 4;13(3):543-550. doi: 10.1080/21645515.2016.1246094. Epub 2016 Nov 7.

28.

Factors associated with diagnostic stage of hip osteoarthritis due to acetabular dysplasia among Japanese female patients: a cross-sectional study.

Ohfuji S, Jingushi S, Kondo K, Sofue M, Itoman M, Matsumoto T, Hamada Y, Shindo H, Takatori Y, Yamada H, Yasunaga Y, Ito H, Mori S, Owan I, Fujii G, Ohashi H, Takahashi S, Hirota Y.

BMC Musculoskelet Disord. 2016 Aug 2;17:320. doi: 10.1186/s12891-016-1179-4.

30.

Immunogenicity and Efficacy of A/H1N1pdm Vaccine Among Subjects With Severe Motor and Intellectual Disability in the 2010/11 Influenza Season.

Hara M, Hanaoka T, Maeda K, Kase T, Ohfuji S, Fukushima W, Hirota Y.

J Epidemiol. 2016 Jun 5;26(6):300-6. doi: 10.2188/jea.JE20150036. Epub 2016 Jan 16.

31.

Risk factors for surgical intestinal disorders in VLBW infants: Case-control study.

Okuyama H, Ohfuji S, Hayakawa M, Urushihara N, Yokoi A, Take H, Shiraishi J, Fujinaga H, Ohashi K, Minagawa K, Misaki M, Nose S, Taguchi T.

Pediatr Int. 2016 Jan;58(1):34-9. doi: 10.1111/ped.12815. Epub 2015 Dec 29.

PMID:
26333186
32.

Reactogenicity of trivalent inactivated influenza vaccine in young children: Pronounced reactions by previous successive vaccinations.

Okada C, Fujieda M, Fukushima W, Ohfuji S, Kondo K, Maeda A, Nakano T, Kaji M, Hirota Y; Influenza Vaccine Epidemiology Study Group.

Vaccine. 2015 Jul 9;33(30):3586-91. doi: 10.1016/j.vaccine.2015.05.040. Epub 2015 Jun 1.

PMID:
26044492
33.

Safety of a Pandemic Influenza Vaccine and the Immune Response in Patients with Duchenne Muscular Dystrophy.

Saito T, Ohfuji S, Matsumura T, Saito T, Maeda K, Maeda A, Fukushima W, Fujimura H, Sakoda S, Hirota Y.

Intern Med. 2015;54(10):1199-205.

34.

Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009-2010 season in Japan: A case-control study.

Kondo K, Suzuki K, Washio M, Ohfuji S, Fukushima W, Maeda A, Hirota Y; Pneumonia in Elderly People Study Group.

Hum Vaccin Immunother. 2015;11(5):1088-93. doi: 10.1080/21645515.2015.1016668. Erratum in: Hum Vaccin Immunother. 2015;11(10):2510.

35.

Detection of influenza vaccine effectiveness among nursery school children: Lesson from a season with cocirculating respiratory syncytial virus.

Nakata K, Fujieda M, Miki H, Fukushima W, Ohfuji S, Maeda A, Kase T, Hirota Y.

Hum Vaccin Immunother. 2015;11(3):545-52. doi: 10.1080/21645515.2015.1011982.

36.

Emphysematous Eosinophilic Lymphangitis in the Ruminal Submucosa of Cattle.

Ohfuji S.

Vet Pathol. 2015 Nov;52(6):1163-6. doi: 10.1177/0300985814568684. Epub 2015 Feb 20.

PMID:
25710949
37.

Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons.

Hiroi S, Morikawa S, Nakata K, Maeda A, Kanno T, Irie S, Ohfuji S, Hirota Y, Kase T.

Hum Vaccin Immunother. 2015;11(2):386-90. doi: 10.1080/21645515.2015.1009338.

38.

Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.

Matsumoto H, Ohfuji S, Watanabe K, Yamagami H, Fukushima W, Maeda K, Kamata N, Sogawa M, Shiba M, Tanigawa T, Tominaga K, Watanabe T, Fujiwara Y, Hirota Y, Arakawa T.

J Gastroenterol. 2015 Aug;50(8):876-86. doi: 10.1007/s00535-015-1042-7. Epub 2015 Feb 12.

PMID:
25672513
39.

Hypoalbuminemia, influenza vaccination and other factors related to the development of pneumonia acquired outside hospitals in southern Japan: A case-control study.

Washio M, Kondo K, Fujisawa N, Harada E, Tashiro H, Mizokami T, Nogami H, Iwanaga T, Nakanishi Y, Suzuki K, Ohfuji S, Fukushima W, Hirota Y; Kyushu Task Force for CAP Risk in the Elderly.

Geriatr Gerontol Int. 2016 Feb;16(2):223-9. doi: 10.1111/ggi.12456. Epub 2015 Feb 5.

PMID:
25656751
40.

Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan.

Hara M, Fukuoka M, Tashiro K, Ozaki I, Ohfuji S, Okada K, Nakano T, Fukushima W, Hirota Y.

BMC Infect Dis. 2015 Feb 6;15:45. doi: 10.1186/s12879-015-0777-3.

41.

Outcome in VLBW infants with surgical intestinal disorder at 18 months of corrected age.

Hayakawa M, Taguchi T, Urushihara N, Yokoi A, Take H, Shiraishi J, Fujinaga H, Ohashi K, Oshiro M, Kato Y, Ohfuji S, Okuyama H.

Pediatr Int. 2015 Aug;57(4):633-8. doi: 10.1111/ped.12594. Epub 2015 May 6.

PMID:
25639880
42.

Effectiveness of acellular pertussis vaccine in a routine immunization program: a multicenter, case-control study in Japan.

Ohfuji S, Okada K, Nakano T, Ito H, Hara M, Kuroki H, Hirota Y.

Vaccine. 2015 Feb 18;33(8):1027-32. doi: 10.1016/j.vaccine.2015.01.008. Epub 2015 Jan 14.

PMID:
25596459
43.

Determinants of participation in prostate cancer screening: a simple analytical framework to account for healthy-user bias.

Tabuchi T, Nakayama T, Fukushima W, Matsunaga I, Ohfuji S, Kondo K, Kawano E, Fukuhara H, Ito Y, Oshima A.

Cancer Sci. 2015 Jan;106(1):108-14. doi: 10.1111/cas.12561. Epub 2014 Dec 3.

44.

Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies.

Ide Y, Imamura Y, Ohfuji S, Fukushima W, Ide S, Tsutsumi C, Koga M, Maeda K, Hirota Y.

Hum Vaccin Immunother. 2014;10(8):2387-94. doi: 10.4161/hv.29094.

45.

Pre-illness isoflavone consumption and disease risk of ulcerative colitis: a multicenter case-control study in Japan.

Ohfuji S, Fukushima W, Watanabe K, Sasaki S, Yamagami H, Nagahori M, Watanabe M, Hirota Y; Japanese Case-Control Study Group for Ulcerative Colitis.

PLoS One. 2014 Oct 14;9(10):e110270. doi: 10.1371/journal.pone.0110270. eCollection 2014.

46.

Immunogenicity of the trivalent inactivated influenza vaccine in young children less than 4 years of age, with a focus on age and baseline antibodies.

Mugitani A, Ito K, Irie S, Eto T, Ishibashi M, Ohfuji S, Fukushima W, Maeda A, Hirota Y; Fukuoka Pediatricians Group for Vaccine Efficacy.

Clin Vaccine Immunol. 2014 Sep;21(9):1253-60. doi: 10.1128/CVI.00200-14. Epub 2014 Jul 2.

47.

Individualized and institutionalized residential place-based discrimination and self-rated health: a cross-sectional study of the working-age general population in Osaka city, Japan.

Tabuchi T, Nakaya T, Fukushima W, Matsunaga I, Ohfuji S, Kondo K, Inui M, Sayanagi Y, Hirota Y, Kawano E, Fukuhara H.

BMC Public Health. 2014 May 13;14:449. doi: 10.1186/1471-2458-14-449.

48.

Immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus: with special reference to age, body mass index, and HbA1c.

Egawa Y, Ohfuji S, Fukushima W, Yamazaki Y, Morioka T, Emoto M, Maeda K, Inaba M, Hirota Y.

Hum Vaccin Immunother. 2014;10(5):1187-94. doi: 10.4161/hv.28252. Epub 2014 Apr 9.

49.

Epidermoid cysts of the rumen in a Holstein-Friesian steer.

Ohfuji S.

J Comp Pathol. 2014 Jul;151(1):80-2. doi: 10.1016/j.jcpa.2014.02.002. Epub 2014 Feb 11.

PMID:
24679853
50.

Factor-associated caregiver burden in medically complex patients with special health-care needs.

Yotani N, Ishiguro A, Sakai H, Ohfuji S, Fukushima W, Hirota Y.

Pediatr Int. 2014 Oct;56(5):742-7. doi: 10.1111/ped.12339. Epub 2014 Sep 17.

PMID:
24628805

Supplemental Content

Loading ...
Support Center